Biotech Values

[dav1234]

Actavis to aquire Forest: Activis to pay $89.48 a share
Actavis will pay $89.48 per share, comprised of $26.04 in cash and 0.3306 of an Actavis share. The price represents a premium of 25% over Forest's close on Friday of $71.39.
The merger would create a company with combined forecast revenues of $15B in 2015 and free cash flow of over $4B.
The firms project potential operating and tax synergies of $1B, not including manufacturing or revenue synergies.
Actavis CEO Paul Bisaro will lead the new firm, while Forest CEO Brent will join Actavis' board. In total, three Forest directors will gain seats on Activis' board.
"The combined company will create blockbuster product franchises in the CNS, Gastroenterology, Women's Health, Urology and Cardiovascular therapeutic categories," Activis says.
Forest's shares surge 32%, while Activis soars 15.7%


http://seekingalpha.com/pr/8985251-actavis-to-acquire-forest-laboratories-inc-for-25-billion-in-an-equity-and-cash-transaction